DarrellJYamashiroMD

Chief, Pediatric Hematology, Oncology, Stem Cell Transplantation Professor, Pediatrics, Columbia University College of Physicians and Surgeons

Dr. Yamashiro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

I am a board certified Pediatric Hematologist/Oncologist interested in neuroblastoma, Wilms tumor, hepatoblastoma and hepatocellular carcinoma.

Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1992 - 1995
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1989 - 1992
New York University School of MedicineClass of 1989

PubMed

16 citations
Stable liver graft post anti-PD1 therapy as a bridge to transplantation in an adolescent with hepatocellular carcinoma.
Elise Kang, Mercedes Martinez, Hanna Moisander-Joyce, Yvonne M Saenger, Adam D Griesemer
Pediatric Transplantation. 2022-05-01
184 citations
Biology and genetics of human neuroblastomas.
Garrett M. Brodeur, John M. Maris, Darrell J. Yamashiro, Michael D. Hogarty, Peter White
Journal of Pediatric Hematology/oncology. 1997-03-01
239 citations
Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma
Eugene S. Kim, Anna Serur, Jianzhong Huang, Christina Manley, Kimberly W. McCrudden
Proceedings of the National Academy of Sciences of the United States of America. 2002-08-20

Identification of TFAP4 (transcription factor AP-4/activating enhancer binding protein) as a potential master regulator/synthetic lethal gene of MYCN amplified neuroblastomaAlex's Lemonade Stand Foundation2013–2015